Submitted by Anonymous (not verified) on 25 June 2025 - 16:10
Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Date of authorisation: 18/02/2019, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Date of authorisation: 18/02/2019, Revision: 8, Status: Authorised